René Heitner

Pivotal trial with plant cell–expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease

Ari Zimran, Einat Brill‐Almon, Raul Chertkoff et al. · Blood · 2011 · 202 citations · Full text

Low-Dose N-Butyldeoxynojirimycin (OGT 918) for Type I Gaucher Disease

René Heitner, Deborah Elstein, Johannes M. F. G. Aerts et al. · Blood Cells Molecules and Diseases · 2002 · 97 citations

Ogt 918, Substrate Reduction Therapy, Pharmacotherapy +2

Hypertension as the major problem of idiopathic arterial calcification of infancy

Laurence S. Milner, René Heitner, Peter D. Thomson et al. · The Journal of Pediatrics · 1984 · 41 citations

Hypertension, Vascular Malformation, Pediatrics +4

Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.

René Heitner, Silke Arndt, Jonathan Levin · PubMed · 2004 · 13 citations

Glucocerebrosidase gene mutations in black South Africans with Gaucher disease

Silke Arndt, René Heitner, A.B. Lane et al. · Blood Cells Molecules and Diseases · 2009 · 11 citations

Genetics, Inherited Metabolic Disease, Genetic Epidemiology +3